---
title: Aldeyra Therapeutics vs Proxima Clinical Research
slug_a: aldeyra
slug_b: proximacro
site: cro
review_signal_gate: closed
canonical_path: /compare/aldeyra/proximacro
generated_by: BioBM Editorial AI
---

# Aldeyra Therapeutics vs Proxima Clinical Research

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Aldeyra Therapeutics (aldeyra) is listed for cro. Biopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions.

Services: 5. Modalities: 1. Indications: 3. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Proxima Clinical Research (proximacro) is listed for cro. Proxima Clinical Research provides integrated regulatory, clinical, and quality solutions for life science companies, with expertise across device and therapeutic development pathways including IDE, 510(k), IND, NDA, and BLA submissions.

Services: 8. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.